I too had the fond hope that the EPS would be circa $45m x 2/400m = 22.5c, but on rereading the November guidance, I noticed footnote 3, which read (3) Earnings before Interest and Taxation and before amortisation of Intangibles relating to the Golding acquisition. Which means I had no idea what EPS might be be for FY19, so I deducted about 25m off my $45m x 2 to get $65m/400m = 16c. It happened to be what one ore more analysts selected 16c, so that was good enough for me. I secretly though it would transpire to be better, I must admit
I had hopped to locate a logical basis for an EPS for FY19, but without any luck. Somebody other than Lucifer may elucidate this matter. One should be able to guesstimate the interest. I hope it transpires to be higher than 16c.
Amortisation of intangibles is a discretionary thing, and that is not a cost that attracts a tax deduction. Consequently, one could ignore it to derive an underlying, or normalised, EPS, and use that times a PER to invent a valuation. So if you took $520+$580 = $1,100m. Take off some interest and then take out 30% tax, you may end up with a number like $1,050 x .7 = $735m NPAT, or an EPS of $735m/400m = 18.4c. If you then apply a PER of 14, you will have an SP valuation of 14 x 18.4c = $2.566.
Maybe somebody will poke through the information and derive a different arithmetic than the foregoing, but I admit to feeling comfortable with $2.56. If we bounce this around between us, we should get a more comfortable set of numbers. I rattled this reply out quickly off the top of my head, so be cautious about agreeing to what I have written too quickly.
- Forums
- ASX - By Stock
- Chart Update
I too had the fond hope that the EPS would be circa $45m x...
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NWH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.83 |
Change
-0.120(3.04%) |
Mkt cap ! $1.574B |
Open | High | Low | Value | Volume |
$3.98 | $3.99 | $3.83 | $7.728M | 1.999M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 48404 | $3.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.85 | 173224 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5058 | 2.370 |
4 | 18795 | 2.360 |
4 | 37687 | 2.350 |
1 | 7879 | 2.340 |
3 | 24992 | 2.330 |
Price($) | Vol. | No. |
---|---|---|
2.390 | 11634 | 3 |
2.400 | 71958 | 7 |
2.410 | 16085 | 2 |
2.420 | 19941 | 3 |
2.460 | 816 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
NWH (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online